<PAGE>
As filed with the Securities and Exchange Commission on October 17, 2000
Registration No. 333-49249
================================================================================
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
POST EFFECTIVE AMENDMENT NO. 1
TO
FORM S-3
REGISTRATION STATEMENT
Under
The Securities Act of 1933
MEDI-JECT CORPORATION
(Exact name of registrant as specified in its charter)
MINNESOTA 41-1350192
(State or other jurisdiction of (I.R.S Employer Identification No.)
incorporation or organization)
161 CHESHIRE LANE, SUITE 100
MINNEAPOLIS, MINNESOTA 55441
(612) 475-7700
(Address, including zip code, and telephone number, including area
code, of registrant's principal executive offices)
FRANKLIN PASS, M.D. Copy to: IVY BERNHARDSON, ESQ.
MEDI-JECT CORPORATION LEONARD, STREET AND DEINARD
161 CHESHIRE LANE, SUITE 100 150 SOUTH FIRST STREET, SUITE 2300
MINNEAPOLIS, MINNESOTA 55441 MINNEAPOLIS, MINNESOTA 55402
(612) 475-7700 (612) 335-1822
(Name, address, including zip code, and telephone number,
including area code, of agent for service)
<PAGE>
This Post-Effective Amendment No. 1 to the Registration Statement on
Form S-3 (Registration No. 333-49249) of Medi-Ject Corporation is being filed to
de-register 15,232 shares of our common stock (which number of shares is without
regard to the stock split that occurred subsequent to the effective date of the
registration statement), which shares remain unsold as of the opening of
business on October 16, 2000. The terms of the offering are described in the
prospectus which was filed as a part of the registration statement.
SIGNATURES AND POWERS OF ATTORNEY
Pursuant to the requirements of the Securities Act of 1933, Medi-Ject
Corporation has duly caused this Post-Effective Amendment No. 1 to the
registration statement to be signed on its behalf by the undersigned, thereunto
duly authorized, in the City of Minneapolis, State of Minnesota, on October 17,
2000.
Medi-Ject Corporation
By: /S/ FRANKLIN PASS, M.D.
------------------------------------
Franklin Pass, M.D.
Chairman and Chief Executive Officer
Pursuant to the requirements of the Securities Act of 1933, this
Post-Effective Amendment No. 1 to the registration statement has been signed by
the following persons in the capacities and on the dates indicated.
<TABLE>
<CAPTION>
SIGNATURE TITLE
--------- -----
<S> <C> <C>
/S/ FRANKLIN PASS, M.D. }
--------------------------- President, Chief Executive Officer and }
Franklin Pass, M.D. Director (principal executive officer) }
}
}
/S/ KENNETH EVENSTAD }
--------------------------- Director }
Kenneth Evenstad }
}
}By: /S/ FRANKLIN PASS, M.D.
-------------------------
/S/ GEOFFREY GUY } Franklin Pass, M.D., as
--------------------------- Director } attorney-in-fact under
Geoffrey Guy } Powers of Attorney dated
} March 16, 1998.
}
/S/ FRED SHAPIRO, M.D. }
--------------------------- Director }
Fred Shapiro, M.D. }
}
}
/S/ STANLEY GOLDBERG }
--------------------------- Director }
Stanley Goldberg }
}
}
/S/ KARL GROTH }
--------------------------- Director }
Karl Groth }
/S/ LAWRENCE M. CHRISTIAN
--------------------------- Vice President - Finance and Administration
Lawrence M. Christian Chief Financial Officer
(principal financial & accounting officer)
</TABLE>
